Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A46593 | 17404845 | Dig Dis Sci | Flare-up of nonalcoholic steatohepatitis after hepatectomy resulted in hepatic failure in a patient with type 2 diabetes mellitus. | 2007 | Details |
| A46594 | 17396083 | Gastroenterol Clin Biol | [Carbohydrate metabolism dysregulation in cirrhosis: pathophysiology, prognostic impact and therapeutic implications]. | 2007 | Details |
| A46596 | 17388108 | Hellenic J Cardiol | Non-alcoholic fatty liver and cardiovascular disease: an emerging relationship. | 2007 | Details |
| A46598 | 17376064 | J Gastroenterol Hepatol | Lifestyle advice in non-alcoholic fatty liver disease. | 2007 | Details |
| A46603 | 17354303 | N Engl J Med | Pioglitazone in nonalcoholic steatohepatitis. | 2007 | Details |
| A46608 | 17318260 | J Clin Invest | Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. | 2007 | Details |
| A46612 | 17296533 | Clin Gastroenterol Hepatol | Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial. | 2007 | Details |
| A46615 | 17275449 | Am J Med | Polycystic ovary syndrome: diagnosis and treatment. | 2007 | Details |
| A46616 | 17274475 | Pol Arch Med Wewn | [Non-alcoholic fatty liver disease]. | 2006 | Details |
| A46619 | 17264787 | Nurse Pract | Nonalcoholic fatty liver disease. | 2007 | Details |
| A46630 | 17114290 | Proc Natl Acad Sci U S A | Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. | 2006 | Details |
| A46637 | 17036578 | Mayo Clin Proc | Long-term outcome of bariatric surgery: an interim analysis. | 2006 | Details |
| A46638 | 16996806 | Clin Gastroenterol Hepatol | Influence of high body mass index on outcome in acute liver failure. | 2006 | Details |
| A46645 | 16932311 | Nat Clin Pract Endocrinol Metab | Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance. | 2006 | Details |
| A46664 | 16767302 | Arq Bras Endocrinol Metabol | [Insulin resistance/hyperinsulinemia associated diseases not included in the metabolic syndrome]. | 2006 | Details |
| A46668 | 16729640 | Br J Hosp Med (Lond) | Non-alcoholic fatty liver disease and diabetes: a 21st century epidemic. | 2006 | Details |
| A46680 | 16584696 | Gastroenterol Hepatol | [Epidemiology and natural history of primary nonalcoholic fatty liver disease]. | 2006 | Details |
| A46693 | 16478772 | Am J Physiol Endocrinol Metab | Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. | 2006 | Details |
| A46702 | 16392439 | Wien Med Wochenschr | Glycated hemoglobin and liver disease in diabetes mellitus. | 2005 | Details |
| A46706 | 16340637 | J Clin Gastroenterol | Liver disease in patients with diabetes mellitus. | 2006 | Details |
| A46733 | 16109522 | Hepatobiliary Pancreat Dis Int | Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients. | 2005 | Details |
| A46738 | 16011474 | Annu Rev Nutr | Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment and prevention beyond body weight modification. | 2005 | Details |
| A46741 | 15990637 | J Pediatr Gastroenterol Nutr | Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. | 2005 | Details |
| A46743 | 15989845 | Med Clin (Barc) | [Medical management of primary nonalcoholic fatty liver disease]. | 2005 | Details |
| A46765 | 15730035 | Ned Tijdschr Geneeskd | [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis]. | 2005 | Details |
| A46781 | 15611492 | Ann Intern Med | Narrative review: hepatobiliary disease in type 2 diabetes mellitus. | 2004 | Details |
| A46785 | 15598693 | J Clin Endocrinol Metab | Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. | 2004 | Details |
| A46788 | 15547646 | Angiology | Prevention and treatment of the metabolic syndrome. | 2005 | Details |
| A46802 | 15262299 | Endocrinol Metab Clin North Am | Glitazones and the management of insulin resistance: what they do and how might they be used. | 2004 | Details |
| A46804 | 15240880 | Proc Natl Acad Sci U S A | Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. | 2004 | Details |
| A46806 | 15195530 | Gastroenterol Hepatol | [Pathogenesis of non-alcoholic fatty liver and potential therapeutic targets]. | 2004 | Details |
| A46808 | 15151470 | Expert Rev Cardiovasc Ther | Treatment of metabolic syndrome. | 2004 | Details |
| A46811 | 15051828 | J Nutr | Mice heterozygous for Atp10c, a putative amphipath, represent a novel model of obesity and type 2 diabetes. | 2004 | Details |
| A46817 | 14749503 | Recent Prog Horm Res | Obesity, insulin resistance, and cardiovascular disease. | 2004 | Details |
| A46823 | 14633828 | Diabetes Care | Nonalcoholic fatty liver disease in Saudi type 2 diabetic subjects attending a medical outpatient clinic: prevalence and general characteristics. | 2003 | Details |
| A46856 | 12527713 | Mod Pathol | Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease. | 2003 | Details |
| A46860 | 12408779 | Curr Treat Options Gastroenterol | Therapeutic Options in Nonalcoholic Fatty Liver Disease. | 2002 | Details |
| A46873 | 12003426 | Am J Gastroenterol | Factors influencing the prevalence of gallstones in liver disease: the beneficial and harmful influences of alcohol. | 2002 | Details |
| A46877 | 19475216 | Rev Bras Anestesiol | Preanesthetic clinical problems of morbidly obese patients submitted to bariatric surgery: comparison with non-obese patiens. | 2002 | Details |
| A46890 | 11296699 | Semin Liver Dis | Treatment of nonalcoholic fatty liver: present and emerging therapies. | 2001 | Details |
| A46895 | 11059435 | Am J Med | Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. | 2000 | Details |
| A46900 | 10726383 | Gastroenterol Hepatol | [Steatosis and nonalcoholic steatohepatitis. A comparative analysis]. | 2000 | Details |
| A46977 | 31493100 | Wien Klin Wochenschr | Patterns and prevalence of dyslipidemia in patients with different etiologies of chronic liver disease. | 2019 | Details |
| A47050 | 27861855 | Int J Cancer | Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study. | 2016 | Details |
| A47087 | 26493454 | BMC Syst Biol | Systems analysis of non-parenchymal cell modulation of liver repair across multiple regeneration modes. | 2015 | Details |
| A47116 | 25702770 | Alcohol Clin Exp Res | Ethnic differences in presentation and severity of alcoholic liver disease. | 2015 | Details |
| A47132 | 25400459 | World J Gastroenterol | Metformin does not improve survival in patients with hepatocellular carcinoma. | 2014 | Details |
| A47238 | 21819471 | Addiction | Alcohol consumption and non-communicable diseases: epidemiology and policy implications. | 2011 | Details |
| A47297 | 18534708 | Diabetes Res Clin Pract | Fatty liver and chronic inflammation in Chinese adults. | 2008 | Details |
| A47381 | 10335777 | Lancet | Non-alcoholic steatohepatitis: another disease of affluence. | 1999 | Details |
| A47384 | 10222605 | Zhonghua Yi Xue Za Zhi (Taipei) | Non-insulin-dependent diabetes mellitus with type I multiple symmetrical lipomatosis: a case report. | 1999 | Details |
| A47385 | 9765002 | J Hepatol | Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance. | 1998 | Details |
| A47570 | 6199945 | Acta Pathol Microbiol Immunol Scand A | Occurrence and significance of Mallory bodies in morbidly obese patients. An immunohistochemical study. | 1984 | Details |
| A47573 | 6627849 | Clin Sci (Lond) | Biochemical analysis of hepatic lipid in alcoholic and diabetic and control subjects. | 1983 | Details |
| A47660 | 34101656 | JBJS Case Connect | Early Postoperative Pneumonia After Elective Primary Total Hip Arthroplasty in "COVID-19 Survivor": A Case Report. | 2021 | Details |
| A47674 | 33860126 | Hepatol Commun | Small Steatotic HCC: A Radiological Variant Associated With Improved Outcome After Ablation. | 2020 | Details |
| A47677 | 33829335 | Surg Today | Predictive scoring system for advanced liver fibrosis in Japanese patients with severe obesity. | 2021 | Details |
| A47679 | 33778934 | Clin Pharmacokinet | Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide. | 2021 | Details |
| A47684 | 33738905 | Obes Rev | Neutral sphingomyelinase-2 and cardiometabolic diseases. | 2021 | Details |
| A47699 | 33491315 | Obesity (Silver Spring) | The Metabolic Equivalent BMI in Patients with Familial Partial Lipodystrophy (FPLD) Compared with Those with Severe Obesity. | 2021 | Details |
| A47712 | 33143193 | Biomolecules | Sphingomyelinases and Liver Diseases. | 2020 | Details |
| A47719 | 33030356 | Expert Rev Endocrinol Metab | Tirzepatide: a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) dual agonist in development for the treatment of type 2 diabetes. | 2020 | Details |
| A47725 | 32908723 | Case Rep Endocrinol | Development of Fulminant Type 1 Diabetes Mellitus in a Patient with DRESS Syndrome. | 2020 | Details |
| A47735 | 32730231 | JCI Insight | Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. | 2020 | Details |
| A47740 | 32650991 | Transplant Proc | Metabolic and Renal Effects of Mammalian Target of Rapamycin Inhibitors Treatment After Liver Transplantation: Real-Life Single-Center Experience. | 2020 | Details |
| A47757 | 32376662 | BMJ Case Rep | Looking beyond appearances: when liver biopsy is the key for hepatic tuberculosis diagnosis. | 2020 | Details |
| A47770 | 32213649 | Endocrinol Diabetes Metab Case Rep | The complicated clinical course in a case of atypical lipodystrophy after development of neutralizing antibody to metreleptin: treatment with setmelanotide. | 2020 | Details |
| A47783 | 31988864 | Euroasian J Hepatogastroenterol | Hepatocellular Carcinoma in Asia: A Challenging Situation. | 2020 | Details |
| A47815 | 31434650 | Diabetes Care | Acquired Generalized Lipodystrophy: A New Cause of Anti-PD-1 Immune-Related Diabetes. | 2019 | Details |
| A47832 | 31190265 | Obes Surg | Metabolic Syndrome Rather than Obesity Alone Is More Significant for Kidney Disease. | 2019 | Details |
| A47837 | 31144046 | Handb Exp Pharmacol | Targeting Bile Acid-Activated Receptors in Bariatric Surgery. | 2019 | Details |
| A47850 | 30976746 | Hepatol Commun | Influence of Type 2 Diabetes Mellitus and Preoperative Hemoglobin A1c Levels on Outcomes of Liver Transplantation. | 2019 | Details |
| A47853 | 30862680 | Diabetes | FGF19 Analog as a Surgical Factor Mimetic That Contributes to Metabolic Effects Beyond Glucose Homeostasis. | 2019 | Details |
| A47858 | 30742277 | Drugs | The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes Mellitus. | 2019 | Details |
| A47870 | 30586642 | J Am Coll Surg | Effect of Renal Diagnosis on Survival in Simultaneous Liver-Kidney Transplantation. | 2018 | Details |
| A47881 | 30141927 | J Med Chem | Design of Gut-Restricted Thiazolidine Agonists of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5). | 2018 | Details |
| A47896 | 29870275 | Diabetes Technol Ther | The Clinical Impact of GLP-1 Receptor Agonists in Type 2 Diabetes: Focus on the Long-Acting Analogs. | 2018 | Details |
| A47913 | 29411291 | Diabetes Ther | Post-Liver Transplantation Diabetes Mellitus: A Review of Relevance and Approach to Treatment. | 2018 | Details |
| A47935 | 28847797 | Circulation | Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors. | 2017 | Details |
| A47945 | 28657848 | AJR Am J Roentgenol | Plasma Glucose Level Is Predictive of Serum Ammonia Level After Retrograde Occlusion of Portosystemic Shunts. | 2017 | Details |
| A47963 | 28008402 | ACG Case Rep J | Dapagliflozin-Induced Acute-on-Chronic Liver Injury. | 2016 | Details |
| A47990 | 27110066 | Mediators Inflamm | Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control. | 2016 | Details |
| A47996 | 26915859 | Transplant Proc | New-Onset Diabetes Mellitus in Liver Transplant Recipients With Hepatitis C: Analysis of the National Database. | 2016 | Details |
| A48016 | 26486483 | Vnitr Lek | [Polycystic ovary syndrome]. | 2015 | Details |
| A48026 | 26123027 | Gut | Anti-angiogenic effect of metformin in human liver carcinogenesis related to metabolic syndrome. | 2015 | Details |
| A48029 | 26075502 | J Dtsch Dermatol Ges | Early detection of comorbidity in psoriasis: recommendations of the National Conference on Healthcare in Psoriasis. | 2015 | Details |
| A48065 | 27278026 | J Med Ultrason (2001) | Real-time tissue elastography (RTE) for noninvasive evaluation of fibrosis in liver diseases in children in comparison to liver biopsy. | 2014 | Details |
| A48083 | 24602085 | Ann N Y Acad Sci | Gastrointestinal morbidity in obesity. | 2014 | Details |
| A48085 | 24585431 | Hepatology | Prevalence and natural history of histologically proven chronic liver disease in a longitudinal cohort of patients with type 1 diabetes. | 2014 | Details |
| A48094 | 24096983 | J Gastroenterol | Occlusion of portosystemic shunts improves hyperinsulinemia due to insulin resistance in cirrhotic patients with portal hypertension. | 2013 | Details |
| A48096 | 23974764 | Curr Opin Endocrinol Diabetes Obes | A complications-based clinical staging of obesity to guide treatment modality and intensity. | 2013 | Details |
| A48104 | 23355033 | J Gastrointest Surg | Prevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma. | 2013 | Details |
| A48113 | 22988496 | Int J Surg Oncol | Resection of nonalcoholic steatohepatitis-associated hepatocellular carcinoma: a Western experience. | 2012 | Details |
| A48114 | 22955269 | J Biol Chem | Increased phosphoenolpyruvate carboxykinase gene expression and steatosis during hepatitis C virus subgenome replication: role of nonstructural component 5A and CCAAT/enhancer-binding protein β. | 2012 | Details |
| A48127 | 22333480 | J Pharmacol Sci | Multiple mechanisms for the action of chymase inhibitors. | 2012 | Details |
| A48129 | 22248781 | Pediatr Endocrinol Diabetes Metab | [Insulin resistance in children]. | 2011 | Details |
| A48134 | 21979752 | Mol Med | p38 mitogen-activated protein kinase and liver X receptor-α mediate the leptin effect on sterol regulatory element binding protein-1c expression in hepatic stellate cells. | 2012 | Details |
| A48149 | 21292266 | Atherosclerosis | Electronegative low-density lipoprotein: origin and impact on health and disease. | 2011 | Details |
| A48150 | 21239437 | Endocrinology | Hypermethylation of hepatic glucokinase and L-type pyruvate kinase promoters in high-fat diet-induced obese rats. | 2011 | Details |
| A48157 | 21107605 | Eur J Pediatr | Obesity, metabolic syndrome, and insulin dynamics in children after craniopharyngioma surgery. | 2010 | Details |